VOLTAGE cohort D: Preoperative chemoradiotherapy followed by consolidation nivolumab plus ipilimumab in patients with locally advanced rectal cancer

被引：0

作者：

Takahashi, Y. ^{[1
]}

Kato, T. ^{[2
]}

Bando, H. ^{[3
]}

Tsukada, Y. ^{[4
]}

Inamori, K. ^{[4
]}

Wakabayashi, M. ^{[5
]}

Kumagai, S. ^{[6
]}

Koyama, S. ^{[6
]}

Kotani, D. ^{[7
]}

Yuki, S. ^{[8
]}

Komatsu, Y. ^{[9
]}

Homma, S. ^{[10
]}

Taketomi, A. ^{[10
]}

Uemura, M. ^{[2
]}

Fukui, M. ^{[5
]}

Kojima, M. ^{[11
]}

Sato, A. ^{[5
]}

Nishikawa, H. ^{[6
]}

Ito, M. ^{[4
]}

Yoshino, T. ^{[7
]}

机构：

[1] Natl Hosp Org Osaka Natl Hosp, Osaka, Japan

[2] Natl Hosp Org, Osaka Natl Hosp, Dept Surg, Osaka, Japan

[3] Natl Canc Ctr Hosp East, Dept Gastroenterol & Gastrointestinal Oncol, Kashiwa, Chiba, Japan

[4] Natl Canc Ctr Hosp East, Dept Colorectal Surg, Kashiwa, Chiba, Japan

[5] Natl Canc Ctr Hosp East, Clin Res Support Off, Kashiwa, Chiba, Japan

[6] Natl Canc Ctr Hosp East, Div Canc Immunol, Exploratory Oncol Res & Clin Trial Ctr, Kashiwa, Chiba, Japan

[7] Natl Canc Ctr Hosp East, Kashiwa, Chiba, Japan

[8] Hokkaido Univ Hosp, Dept Gastroenterol & Hepatol, Sapporo, Hokkaido, Japan

[9] Hokkaido Univ Hosp, Div Canc Ctr, Sapporo, Hokkaido, Japan

[10] Hokkaido Univ Hosp, Dept Gastroenterol Surg, Sapporo, Hokkaido, Japan

[11] Natl Canc Ctr Hosp East, Exploratory Oncol Res & Clin Trial Ctr, Div Pathol, Kashiwa, Chiba, Japan

来源：

ANNALS OF ONCOLOGY | 2023年 / 34卷

关键词：

D O I：

10.1016/j.annonc.2023.04.228

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

P-172

引用

页码：S77 / S77

页数：1

共 50 条

[31] VOLTAGE: Investigator -initiated clinical trial of nivolumab monotherapy and subsequent radical surgery following preoperative chemoradiotherapy in patients with microsatellite stable locally advanced rectal cancer
Yashino, T.
Bando, H.
Tsukada, Y.
Inamori, K.
Yuki, S.
Komatsu, Y.
Homma, S.
Uemura, M.
Kato, T.
Kotani, D.
Fukuoka, S.
Sasaki, T.
Nishizawa, Y.
Nakamura, N.
Wakabayashi, M.
Kojima, M.
Togashi, Y.
Sato, A.
Nishikawa, H.
Ito, M.
ANNALS OF ONCOLOGY, 2019, 30 : 129 - 129
[32] Ipilimumab plus nivolumab and chemoradiotherapy followed by surgery in patients with resectable and borderline resectable lung cancer: The INCREASE trial
Bahce, I.
Dickhoff, C.
Schneiders, F. L.
Veltman, J.
Heineman, D. J.
Hashemi, S.
Fransen, M.
Vrijmoet, A.
Houda, I.
Ulas, E.
van de Ven, P.
Bouwhuis, N.
Meijboom, L.
Oprea-Lager, D.
Vallejo, J. Garcia
de Gruijl, T. D.
Radonic, T.
Senan, S.
ANNALS OF ONCOLOGY, 2022, 33 (07) : S982 - S982
[33] Three-year outcomes of preoperative chemoradiotherapy plus nivolumab in microsatellite stable and microsatellite instability-high locally advanced rectal cancer
Tsukada, Yuichiro
Bando, Hideaki
Inamori, Koji
Wakabayashi, Masashi
Togashi, Yosuke
Koyama, Shohei
Kotani, Daisuke
Yuki, Satoshi
Komatsu, Yoshito
Homma, Shigenori
Taketomi, Akinobu
Uemura, Mamoru
Kato, Takeshi
Fukui, Makoto
Nakamura, Naoki
Kojima, Motohiro
Kawachi, Hiroshi
Kirsch, Richard
Yoshida, Tsutomu
Sato, Akihiro
Nishikawa, Hiroyoshi
Ito, Masaaki
Yoshino, Takayuki
BRITISH JOURNAL OF CANCER, 2024, 131 (02) : 283 - 289
[34] Role of IDO expression in patients with locally advanced rectal cancer treated with preoperative chemoradiotherapy
Takasu, Chie
Nishi, Masaaki
Yoshikawa, Kozo
Tokunaga, Takuya
Nakao, Toshihiro
Kashihara, Hideya
Wada, Yuma
Yoshimoto, Toshiaki
Okikawa, Shohei
Yamashita, Shoko
Shimada, Mitsuo
BMC CANCER, 2022, 22 (01)
[35] Prognostic significance of pathological response to preoperative chemoradiotherapy in patients with locally advanced rectal cancer
Ayako Tomono
Kimihiro Yamashita
Kiyonori Kanemitsu
Yasuo Sumi
Masashi Yamamoto
Shingo Kanaji
Tatsuya Imanishi
Tetsu Nakamura
Satoshi Suzuki
Kenichi Tanaka
Yoshihiro Kakeji
International Journal of Clinical Oncology, 2016, 21 : 344 - 349
[36] Artemis as Predictive Biomarker of Responsiveness to Preoperative Chemoradiotherapy in Patients with Locally Advanced Rectal Cancer
Liu, Hai
Huang, Runying
Shan, Jingjing
Xie, Xuyun
Wang, Chongwei
Hu, Peng
Sun, Xiaonan
CURRENT ONCOLOGY, 2024, 31 (01) : 535 - 546
[37] Prognostic significance of pathological response to preoperative chemoradiotherapy in patients with locally advanced rectal cancer
Tomono, Ayako
Yamashita, Kimihiro
Kanemitsu, Kiyonori
Sumi, Yasuo
Yamamoto, Masashi
Kanaji, Shingo
Imanishi, Tatsuya
Nakamura, Tetsu
Suzuki, Satoshi
Tanaka, Kenichi
Kakeji, Yoshihiro
INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2016, 21 (02) : 344 - 349
[38] Role of IDO expression in patients with locally advanced rectal cancer treated with preoperative chemoradiotherapy
Chie Takasu
Masaaki Nishi
Kozo Yoshikawa
Takuya Tokunaga
Toshihiro Nakao
Hideya Kashihara
Yuma Wada
Toshiaki Yoshimoto
Shohei Okikawa
Shoko Yamashita
Mitsuo Shimada
BMC Cancer, 22
[39] Preoperative ipilimumab plus nivolumab in locoregionally advanced urothelial cancer: the NABUCCO trial
Nick van Dijk
Alberto Gil-Jimenez
Karina Silina
Kees Hendricksen
Laura A. Smit
Jeantine M. de Feijter
Maurits L. van Montfoort
Charlotte van Rooijen
Dennis Peters
Annegien Broeks
Henk G. van der Poel
Annemarie Bruining
Yoni Lubeck
Karolina Sikorska
Thierry N. Boellaard
Pia Kvistborg
Daniel J. Vis
Erik Hooijberg
Ton N. Schumacher
Maries van den Broek
Lodewyk F. A. Wessels
Christian U. Blank
Bas W. van Rhijn
Michiel S. van der Heijden
Nature Medicine, 2020, 26 : 1839 - 1844
[40] Preoperative ipilimumab plus nivolumab in locoregionally advanced urothelial cancer: the NABUCCO trial
van Dijk, Nick
Gil-Jimenez, Alberto
Silina, Karina
Hendricksen, Kees
Smit, Laura A.
de Feijter, Jeantine M.
van Montfoort, Maurits L.
van Rooijen, Charlotte
Peters, Dennis
Broeks, Annegien
van der Poel, Henk G.
Bruining, Annemarie
Lubeck, Yoni
Sikorska, Karolina
Boellaard, Thierry N.
Kvistborg, Pia
Vis, Daniel J.
Hooijberg, Erik
Schumacher, Ton N.
van den Broek, Maries
Wessels, Lodewyk F. A.
Blank, Christian U.
van Rhijn, Bas W.
van der Heijden, Michiel S.
NATURE MEDICINE, 2020, 26 (12) : 1839 - 1844

← 1 2 3 4 5 →